Clinical Trials Directory

Trials / Completed

CompletedNCT01211366

Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions

Post-operative Infusion of Intra-operative Cell Salvage Reduces Allogeneic Blood Product Transfusions and Volume Resuscitation in Pediatric Cardiac Surgery and Improves Clinical Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Transfusion of washed intra-operative cell salvage post-operatively in the PCICU can be performed safely without increased risk of bleeding or release of inflammatory mediators. This will reduce the need for allogeneic blood products as well as crystalloid and colloid infusions and thus decrease the length of ventilation and intensive care duration for these infants.

Conditions

Interventions

TypeNameDescription
OTHERCell Saver RBCsUse of cell saver RBCs to decrease the infusion of allogeneic PRBCs, crystalloid, and colloid in post-operative infants following CPB as needed for hemodynamic instability
OTHERConventional volume infusionInfusion of allogeneic PRBCs, crystalloid, and colloid as needed for hemodynamic instability

Timeline

Start date
2010-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-09-29
Last updated
2012-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01211366. Inclusion in this directory is not an endorsement.